From: Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients
Variables | MPE | BPE | P-value |
---|---|---|---|
Patients, n | 78 | 45 | |
Mean age (±SD), years | 56.3 ± 12.5 | 55.6 ± 11.7 | >0.05 |
Male/female | 36/42 | 34/11 | >0.05 |
MPE | |||
Adenocarcinoma | 67 | ND | |
Squamous cell carcinoma | 5 | ND | |
Small-cell lung carcinoma | 6 | ND | |
BPE | |||
Tuberculous | ND | 28 | |
Parapneumonic | ND | 12 | |
Heart failure | ND | 5 | |
Diagnostic method | |||
Biochemistry | ND | 30 | |
Cytology | 50 | ND | |
Pleural biopsy | 6 | 8 | |
Percutaneous biopsy | 12 | 4 | |
Endoscopic examination | 10 | 3 |